Odevixibat-d5 | MedChemExpress (MCE)
Odevixibat-d5 is deuterated labeled Odevixibat (HY-109120). Odevixibat (A4250) is a selective and orally active ileal apical sodium-dependent bile acid transporter (ASBT) inhibitor. Odevixibat decreases cholestatic liver and bile duct injury in mice model. Odevixibat has the potential for the treatment of primary biliary cirrhosis[1].
| Trivial name | Odevixibat-d5 |
| Catalog Number | HY-109120S |
| Alternative Name(s) | A4250-d5 |
| Research Area | Metabolic Disease |
| Purity | ≥98.0% |
| SMILES | [2H]C1=C(C([2H])=C(C([2H])=C1[2H])N2CC(CCCC)(NS(=O)(C3=CC(OCC(N[C@H](C4=CC=C(C=C4)O)C(N[C@H](C(O)=O)CC)=O)=O)=C(C=C32)SC)=O)CCCC)[2H] |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/odevixibat-d5.html |